- Home
- / Principia BioPharma
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Principia BioPharma financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Revenue
$35.2 M
FY, 2019
CreditSafe Score
?
Score changed on Jun 09, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| USD | FY, 2016 | FY, 2017 | FY, 2018 | FY, 2019 |
|---|---|---|---|---|
| Revenue | 5.2M | 69.1M | 35.2M | |
| General and administrative expense | 4.8M | 6.4M | 11.5M | 19.8M |
| Operating expense total | 27.1M | 31.8M | 52.0M | 93.9M |
| EBIT | (27.1M) | (26.6M) | 17.1M | (58.8M) |
| EBIT margin, % | -506.7% | 24.8% | -167.1% | |
| Interest income | 1.7M | 5.0M | ||
| Interest expense | 3.9M | 7.2M | ||
| Pre tax profit | 18.2M | (53.8M) | ||
| Income tax expense | 800.0 | 800.0 | ||
| Net Income | (30.6M) | (28.7M) | 18.2M | (53.8M) |